XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.20.2

Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2020
Segment Reporting [Abstract] |
Segment Information | Segment Information We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature’s Sunshine Products and Synergy® WorldWide brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market. Historically, our operating segments were based on brand, customer base, geographical operations with three operating business segments under the Nature’s Sunshine Products brand (NSP Americas; NSP Russia, Central and Eastern Europe; and NSP China), and one operating business segment under the Synergy® WorldWide brand. During the second quarter of 2019, we realigned into geographic focused operating business segments across brands to further align regional strategies and drive synergies in product, organizational and go-to-market strategies in local markets. Our internal reporting structure was reorganized to support the new reporting segments and the chief operating decision maker now reviews the operating results of the four segments utilizing a geographic focused format. The presentation of the comparative information has been recast to conform to the 2019 realignment. Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses. Reportable business segment information is as follows (dollar amounts in thousands):
| Three Months Ended June 30, |  |  |  | Six Months Ended June 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
Net sales: |  |  |  |  |  |  |
Asia | $ | 32,757 |  |  | $ | 35,162 |  |  | $ | 63,715 |  |  | $ | 68,758 |
Europe | 15,465 |  |  | 15,075 |  |  | 36,092 |  |  | 30,672 |
North America | 34,471 |  |  | 34,620 |  |  | 73,228 |  |  | 71,143 |
Latin America and Other | 4,593 |  |  | 5,867 |  |  | 10,177 |  |  | 11,423 |
Total net sales | 87,286 |  |  | 90,724 |  |  | 183,212 |  |  | 181,996 |
Contribution margin (1): |  |  |  |  |  |  |
Asia | 16,052 |  |  | 16,677 |  |  | 30,579 |  |  | 32,402 |
Europe | 5,202 |  |  | 4,886 |  |  | 12,033 |  |  | 9,827 |
North America | 11,904 |  |  | 11,625 |  |  | 26,323 |  |  | 25,418 |
Latin America and Other | 1,946 |  |  | 2,369 |  |  | 4,396 |  |  | 4,740 |
Total contribution margin | 35,104 |  |  | 35,557 |  |  | 73,331 |  |  | 72,387 |
Selling, general and administrative expenses (2) | 28,504 |  |  | 31,019 |  |  | 59,569 |  |  | 64,871 |
Operating income | 6,600 |  |  | 4,538 |  |  | 13,762 |  |  | 7,516 |
Other income (loss), net | 1,509 |  |  | 306 |  |  | (901) |  |  | 258 |
Income before provision for income taxes | $ | 8,109 |  |  | $ | 4,844 |  |  | $ | 12,861 |  |  | $ | 7,774 |
_________________________________________ (1) Contribution margin consists of net sales less cost of sales and volume incentives expense. (2) Service fees in China totaled $2.9 million and $4.8 million for the three and six-month periods ended June 30, 2020, respectively, compared to $2.3 million and $4.5 million for the three and six-month periods ended June 30, 2019. These service fees are included in selling, general and administrative expenses. From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and six-month periods ended June 30, 2020 and 2019, as follows (dollar amounts in thousands):
| Three Months Ended June 30, |  |  |  | Six Months Ended June 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
Net sales: |  |  |  |  |  |  |
United States | $ | 32,147 |  |  | $ | 32,194 |  |  | $ | 67,986 |  |  | $ | 66,155 |
South Korea | 14,466 |  |  | 18,923 |  |  | 30,855 |  |  | 37,451 |
Other | 40,673 |  |  | 39,607 |  |  | 84,371 |  |  | 78,390 |
| $ | 87,286 |  |  | $ | 90,724 |  |  | $ | 183,212 |  |  | $ | 181,996 |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
| Three Months Ended June 30, |  |  |  | Six Months Ended June 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
Asia |  |  |  |  |  |  |
General health | $ | 8,263 |  |  | $ | 10,752 |  |  | $ | 17,309 |  |  | $ | 18,836 |
Immune | 179 |  |  | 199 |  |  | 380 |  |  | 357 |
Cardiovascular | 9,323 |  |  | 11,561 |  |  | 18,662 |  |  | 23,394 |
Digestive | 8,391 |  |  | 7,333 |  |  | 14,547 |  |  | 12,108 |
Personal care | 1,877 |  |  | 1,820 |  |  | 4,882 |  |  | 6,087 |
Weight management | 4,724 |  |  | 3,497 |  |  | 7,935 |  |  | 7,976 |
| 32,757 |  |  | 35,162 |  |  | 63,715 |  |  | 68,758 |
Europe |  |  |  |  |  |  |
General health | $ | 6,816 |  |  | $ | 5,372 |  |  | $ | 14,776 |  |  | $ | 11,120 |
Immune | 1,370 |  |  | 1,090 |  |  | 3,814 |  |  | 2,363 |
Cardiovascular | 2,215 |  |  | 2,766 |  |  | 5,112 |  |  | 5,617 |
Digestive | 3,781 |  |  | 3,550 |  |  | 8,713 |  |  | 7,181 |
Personal care | 718 |  |  | 1,661 |  |  | 2,469 |  |  | 3,160 |
Weight management | 565 |  |  | 636 |  |  | 1,208 |  |  | 1,231 |
| 15,465 |  |  | 15,075 |  |  | 36,092 |  |  | 30,672 |
North America |  |  |  |  |  |  |
General health | $ | 14,887 |  |  | $ | 14,934 |  |  | $ | 30,351 |  |  | $ | 30,682 |
Immune | 5,049 |  |  | 3,340 |  |  | 12,847 |  |  | 7,558 |
Cardiovascular | 3,679 |  |  | 4,935 |  |  | 7,846 |  |  | 10,011 |
Digestive | 7,858 |  |  | 8,523 |  |  | 16,099 |  |  | 17,244 |
Personal care | 1,975 |  |  | 1,598 |  |  | 3,904 |  |  | 2,946 |
Weight management | 1,023 |  |  | 1,290 |  |  | 2,181 |  |  | 2,702 |
| 34,471 |  |  | 34,620 |  |  | 73,228 |  |  | 71,143 |
Latin America and Other |  |  |  |  |  |  |
General health | $ | 1,350 |  |  | $ | 1,783 |  |  | $ | 2,964 |  |  | $ | 3,395 |
Immune | 380 |  |  | 602 |  |  | 1,489 |  |  | 1,210 |
Cardiovascular | 263 |  |  | 361 |  |  | 641 |  |  | 700 |
Digestive | 2,264 |  |  | 2,645 |  |  | 4,326 |  |  | 5,181 |
Personal care | 212 |  |  | 260 |  |  | 464 |  |  | 517 |
Weight management | 124 |  |  | 216 |  |  | 293 |  |  | 420 |
| 4,593 |  |  | 5,867 |  |  | 10,177 |  |  | 11,423 |
| $ | 87,286 |  |  | $ | 90,724 |  |  | $ | 183,212 |  |  | $ | 181,996 |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
| June 30, 2020 |  | December 31, 2019
Property, plant and equipment: |  |  |
United States | $ | 52,467 |  |  | $ | 54,470 |
Other | 4,220 |  |  | 5,042 |
Total property, plant and equipment, net | $ | 56,687 |  |  | $ | 59,512 |
Total assets per segment is set forth below (dollar amounts in thousands):
| June 30, 2020 |  | December 31, 2019
Assets: |  |  |
Asia | $ | 72,608 |  |  | $ | 65,959 |
Europe | 17,952 |  |  | 15,187 |
North America | 128,358 |  |  | 124,337 |
Latin America and Other | 8,011 |  |  | 7,585 |
Total assets | $ | 226,929 |  |  | $ | 213,068 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration